114
Participants
Start Date
July 2, 2013
Primary Completion Date
October 11, 2018
Study Completion Date
October 11, 2018
OnabotulinumtoxinA
OnabotulinumtoxinA injected into the detrusor wall on Day 1.
UZ Antwerpen, Antwerp
UZ Leuven, Leuven
Ankara University Medical Faculty Cebeci Hospital, Ankara
UZ Gent , Urology, Ghent
Pediatric Urology Associates, PC, Tarrytown
Duke University Health System, Durham
McKay Urology Carolinas Medical Center, Charlotte
Medical University of South Carolina, Charleston
Hopital Pellegrin - Enfants, Bordeaux
University of Alabama at Birmingham, Birmingham
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children, Indianapolis
William Beaumont Hospital Research Institute, Royal Oak
Fakultni nemocnice Hradec Kralove, Hradec Králové
Children's Hospital of Wisconsin, Milwaukee
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Washington University School of Medicine, St Louis
Oklahoma Childrens Hospital, Oklahoma City
Hopital Trousseau, Paris
Necker Enfants Malades Hospital, Paris
Fakultni nemocnice Olomouc, Olomouc
Seconda Università di Napoli, Caserta
CHU de Limoges - Hopital Mere et l'Enfant, Limoges
Cedars-Sinai Medical Center, Los Angeles
Children's Hospital of Orange County, Orange
McMaster University Medical Centre, Hamilton
CHU Sainte-Justine, Montreal
IRCCS Ospedale Pediatrico Bambino Gesu, Roma
Copernicus Podmiot Leczniczy Sp. z o. o., Kliniczny Oddzial Chirurgii i Urologii Dzieci i Mlodziezy GUMed, Gdansk
Specjalistyczny Gabinet Lekarski, Poznan
Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wroclawiu, Wroclaw
Lead Sponsor
Allergan
INDUSTRY